Protagenic Therapeutics, Inc.\new Conversion of Stock, Shares Issued
Protagenic Therapeutics, Inc.\new (PTIX) had Conversion of Stock, Shares Issued of 10.15 million shares as of 2016-07-27, per its 10-K/A filed 2017-05-08.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesIssued1 · last filed 2017-05-08
- 2016-07-27: Conversion of Stock, Shares Issued 10.15M shares.
| Period end | Conversion of Stock, Shares Issued |
|---|---|
| 2016-07-27 | 10.15M shares 10-K/A · filed 2017-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |